Evidence map›Paper›PMID 33822981›Full record

ArticleThe Journal of infectious diseases2021

Neutrophil-Derived Tumor Necrosis Factor Drives Fungal Acute Lung Injury in Chronic Granulomatous Disease.

R Elaine Cagnina, Kathryn R Michels, Alexandra M Bettina, Marie D Burdick, Yogesh Scindia, Zhimin Zhang, Thomas J Braciale, Borna Mehrad

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Fun-Guide to Innate Immune Responses to Fungal Infections.Journal of fungi (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

R Elaine CagninaDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4210-7928
Kathryn R MichelsDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
Alexandra M BettinaDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
Marie D BurdickDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville,Virginia, USA.
Yogesh ScindiaDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.
Zhimin ZhangDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville,Virginia, USA.
Thomas J BracialeBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA.
Borna MehradDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.
University of Virginia · USUniversity of Florida · USBrigham and Women's Hospital · USCarter Center · US

Funding

Multiscale modeling of the role of heme during invasive pulmonary aspergillosisR01AI135128 · NIAID · UNIVERSITY OF FLORIDA · PI REINHARD LAUBENBACHER, Borna Mehrad · 2018 to 2026
$4.9M
T Cell Function in Pulmonary Viral Pulmonary Infection and InjuryR01HL033391 · NHLBI · WASHINGTON UNIVERSITY · PI BRACIALE, THOMAS J · 1985 to 2012
$4.3M
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.U01EB024501 · NIBIB · UNIVERSITY OF FLORIDA · PI LAUBENBACHER, REINHARD, MEHRAD, BORNA · 2017 to 2020
$2.9M
Regulation of dendritic cell function by neutrophil-derived reactive oxygen species in pulmonary aspergillosisK08HL136903 · NHLBI · UNIVERSITY OF VIRGINIA · PI CAGNINA, REBECCA ELAINE · 2017 to 2021
$894k
Neutrophils and adaptive immunity against invasive aspergillosisR21AI117397 · NIAID · UNIVERSITY OF VIRGINIA · PI MEHRAD, BORNA · 2015 to 2016
$435k
NHLBI NIH HHS K08 HL136903NHLBI NIH HHS R01 HL033391NIAID NIH HHS R01 AI135128NIAID NIH HHS R21 AI117397NIBIB NIH HHS U01 EB024501
6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) results from deficiency of nicotinamide adenine dinucleotide phosphate(NADPH) oxidase and impaired reactive oxygen species (ROS) generation. This leads to impaired killing of Aspergillus and, independently, a pathologic hyperinflammatory response to the organism. We hypothesized that neutrophil-derived ROS inhibit the inflammatory response to Aspergillus and that acute lung injury in CGD is due to failure of this regulation. Mice with gp91phox deficiency, the most common CGD mutation, had more severe lung injury, increased neutrophilinfiltration, and increased lung tumor necrosis factor (TNF) after Aspergillus challenge compared with wild-types. Neutrophils were surprisingly the predominant source of TNF in gp91phox-deficient lungs. TNF neutralization inhibited neutrophil recruitment in gp91phox-deficient mice and protected from lung injury. We propose that, in normal hosts, Aspergillus stimulates TNF-dependent neutrophil recruitment to the lungs and neutrophil-derived ROS limit inflammation. In CGD, in contrast, recruited neutrophils are the dominant source of TNF, promoting further neutrophil recruitment in a pathologic positive-feedback cycle, resulting in progressive lung injury.

Indexed as

Granulomatous Disease, ChronicTumor Necrosis Factor-alphaAcute Lung InjuryAnimalsFungiMiceMice, KnockoutNADPH OxidasesNeutrophilsReactive Oxygen SpeciesReverse Transcriptase Polymerase Chain ReactionNADPH OxidasesReactive Oxygen SpeciesTumor Necrosis Factor-alphaAspergilluschronic granulomatous diseaseneutrophilreactive oxygen speciesTNF

Identifiers

PMID33822981
PMCPMC8682762
OpenAlexW3149693047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.